Nothing Special   »   [go: up one dir, main page]

MX357561B - Antibióticos peptídicos lineales. - Google Patents

Antibióticos peptídicos lineales.

Info

Publication number
MX357561B
MX357561B MX2014009899A MX2014009899A MX357561B MX 357561 B MX357561 B MX 357561B MX 2014009899 A MX2014009899 A MX 2014009899A MX 2014009899 A MX2014009899 A MX 2014009899A MX 357561 B MX357561 B MX 357561B
Authority
MX
Mexico
Prior art keywords
compounds
linear peptide
peptide antibiotics
broad spectrum
bioactivity
Prior art date
Application number
MX2014009899A
Other languages
English (en)
Other versions
MX2014009899A (es
Inventor
I Higuchi Robert
Curran Roberts Tucker
Andrew Smith Peter
Campbell David
Paraselli Prasuna
Original Assignee
Rqx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rqx Pharmaceuticals Inc filed Critical Rqx Pharmaceuticals Inc
Publication of MX2014009899A publication Critical patent/MX2014009899A/es
Publication of MX357561B publication Critical patent/MX357561B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a compuestos antibacterianos, en que los compuestos, en algunas realizaciones, tienen bioactividad de amplio espectro. Los compuestos que se proporcionan en el presente documento pueden superar, en otras realizaciones, la resistencia transmitida por mutaciones de un solo aminoácido en las posiciones definidas de Peptidasas de Señal bacterianas (SPasas) y, en otras realizaciones, pueden proporcionar un amplio espectro de bioactividad antibiótica. Además, se proporcionan composiciones farmacéuticas y métodos de tratamiento que usan los compuestos que se describen en el presente documento.
MX2014009899A 2012-02-16 2013-02-15 Antibióticos peptídicos lineales. MX357561B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261599851P 2012-02-16 2012-02-16
US201261730928P 2012-11-28 2012-11-28
PCT/US2013/026520 WO2013123456A1 (en) 2012-02-16 2013-02-15 Linear peptide antibiotics

Publications (2)

Publication Number Publication Date
MX2014009899A MX2014009899A (es) 2015-03-09
MX357561B true MX357561B (es) 2018-07-13

Family

ID=48982724

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014009899A MX357561B (es) 2012-02-16 2013-02-15 Antibióticos peptídicos lineales.

Country Status (12)

Country Link
US (3) US8999922B2 (es)
EP (1) EP2814807A4 (es)
JP (2) JP2015509942A (es)
KR (1) KR20140132367A (es)
CN (1) CN104254518A (es)
AR (1) AR091310A1 (es)
CA (1) CA2864669A1 (es)
EA (1) EA201491511A1 (es)
HK (1) HK1205736A1 (es)
MX (1) MX357561B (es)
TW (1) TWI601746B (es)
WO (1) WO2013123456A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2814807A4 (en) * 2012-02-16 2015-10-07 Rqx Pharmaceuticals Inc LINEAR PEPTIDANTIBIOTICS
EP2961765A4 (en) * 2013-03-15 2016-11-09 Adaerata Ltd Partnership SMALL MOLECULAR PCSK9 MODULATORS AND METHOD OF USE THEREOF
RU2016107436A (ru) * 2013-08-14 2017-09-19 АрКьюЭкс ФАРМАСЬЮТИКЛС, ИНК. Линейные пептидные антибиотики
MX2017013304A (es) 2015-04-14 2018-08-01 B Organic Films Corp Agentes antivirales y antibacterianos basados en un compuesto de amonio cuaternario formando complejos con acido borico y sus derivados.
DK3464336T3 (da) 2016-06-01 2022-05-09 Athira Pharma Inc Forbindelser
EP3472151A4 (en) 2016-06-21 2020-03-04 Orion Ophthalmology LLC CARBOCYCLIC PROLINAMIDE DERIVATIVES
DK3472149T3 (da) 2016-06-21 2023-11-27 Orion Ophthalmology LLC Heterocykliske prolinamidderivater
KR102042600B1 (ko) * 2018-02-13 2019-11-08 전북대학교산학협력단 항산화 및 항염증 활성을 갖는 홍갯지렁이 유래 신규 펩타이드 및 이의 이용
EP3946364A4 (en) * 2019-04-02 2023-01-18 Venatorx Pharmaceuticals, Inc. SOLID FORMS OF ORALLY ADMINISTRATED BETA-LACTAMASE INHIBITOR AND USES THEREOF

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499082A (en) * 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
EP1136498A1 (en) * 1996-10-18 2001-09-26 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease
PL192280B1 (pl) * 1996-10-18 2006-09-29 Vertex Pharma Inhibitory proteaz serynowych, a zwłaszcza proteazy wirusa NS3 zapalenia wątroby C, kompozycja farmaceutyczna i zastosowania
GB9623908D0 (en) * 1996-11-18 1997-01-08 Hoffmann La Roche Amino acid derivatives
GB9902399D0 (en) 1999-02-03 1999-03-24 Smithkline Beecham Plc Compounds
WO2001058471A2 (en) * 2000-02-10 2001-08-16 Intermune, Inc. Novel amino acid and peptide inhibitors of staphylococcus virulence
AR029851A1 (es) * 2000-07-21 2003-07-16 Dendreon Corp Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
US7244815B2 (en) * 2001-05-23 2007-07-17 The Curators Of The University Of Missouri Attachment and elaboration strategies for inverse peptide synthesis
EP1545572A4 (en) 2001-05-23 2006-04-12 Dendreon Corp CELL SURFACE PROTEINS ACTIVATED CONJUGATES AND THERAPEUTIC USES THEREOF
US20040229955A1 (en) * 2003-01-08 2004-11-18 Andersen Niels H. Antibacterial agents
TW201127828A (en) * 2003-09-05 2011-08-16 Vertex Pharma Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
KR20130028078A (ko) * 2010-03-09 2013-03-18 머크 캐나다 인크. 베타-락탐 항박테리아제의 활성을 강화시키는 가교된 리포글리코펩티드
EP2814807A4 (en) * 2012-02-16 2015-10-07 Rqx Pharmaceuticals Inc LINEAR PEPTIDANTIBIOTICS

Also Published As

Publication number Publication date
US8999922B2 (en) 2015-04-07
KR20140132367A (ko) 2014-11-17
CA2864669A1 (en) 2013-08-22
EP2814807A4 (en) 2015-10-07
TW201341403A (zh) 2013-10-16
MX2014009899A (es) 2015-03-09
TWI601746B (zh) 2017-10-11
US20170275334A1 (en) 2017-09-28
JP2018135334A (ja) 2018-08-30
CN104254518A (zh) 2014-12-31
HK1205736A1 (en) 2015-12-24
US20150166605A1 (en) 2015-06-18
WO2013123456A1 (en) 2013-08-22
US20130217619A1 (en) 2013-08-22
US9708368B2 (en) 2017-07-18
AR091310A1 (es) 2015-01-28
JP2015509942A (ja) 2015-04-02
EP2814807A1 (en) 2014-12-24
EA201491511A1 (ru) 2014-12-30

Similar Documents

Publication Publication Date Title
MX357561B (es) Antibióticos peptídicos lineales.
WO2012166665A3 (en) Broad spectrum antibiotics
MX2015006340A (es) Antibioticos macrociclicos de amplio espectro.
NZ618571A (en) Peptides and their use
MX2016001927A (es) Antibióticos de péptidos lineales.
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
MX2014011067A (es) Analogos de antibiótico de arilomicina de amplio espectro.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
NZ602544A (en) Crystalline forms of a macrolide, and uses therefor
MX364942B (es) Peptidos antimicrobianos.
MX2013003035A (es) Analogos de arilomicina como antibióticos de amplio espectro.
MX2018006190A (es) Antibioticos de amplio espectro macrociclico.
WO2014022382A3 (en) Antibacterial protein kinase inhibitors
MX2018006199A (es) Antibioticos de amplio espectro macrociclico.
MX2016007626A (es) Peptido antimicrobiano y usos del mismo.
PH12019501904A1 (en) Macrocyclic broad spectrum antibiotics
PH12018500358A1 (en) Compounds for use in an antibacterial applications
MX2015015251A (es) Derivados de la quinolona.
PH12015500518A1 (en) Tricyclic tetrahydroquinoline antibacterial agents
PH12015501428A1 (en) Antibacterial compounds
UA94177C2 (en) antimicrobial composition
WO2015063608A9 (en) Use of peptides in antibiotic resistance
WO2014033744A3 (en) A novel pharmaceutical composition of linezolid
WO2014147578A3 (en) Antibacterial compounds against drug resistant bacteria
MY171941A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FG Grant or registration